1984
DOI: 10.1016/s0040-4039(01)80180-5
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of deoxynucleoside methylphosphonates via a phosphonamidite approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
38
0

Year Published

1984
1984
2009
2009

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(38 citation statements)
references
References 8 publications
0
38
0
Order By: Relevance
“…Synthesis and Characterization of the Analogue Operator Sequences. A single racemic methylphosphonate linkage can be introduced into a DNA sequence (Botfield & Weiss, 1994) using a solid-phase-based protocol (Miller et al, 1991) and the methylphosphonamidite nucleoside building block (Dorman et al, 1984;Jager & Engels, 1984;Agrawal & Goodchild, 1987). However, the resulting diastereomeric mixture can only be resolved in the case of relatively short sequences.…”
Section: Resultsmentioning
confidence: 99%
“…Synthesis and Characterization of the Analogue Operator Sequences. A single racemic methylphosphonate linkage can be introduced into a DNA sequence (Botfield & Weiss, 1994) using a solid-phase-based protocol (Miller et al, 1991) and the methylphosphonamidite nucleoside building block (Dorman et al, 1984;Jager & Engels, 1984;Agrawal & Goodchild, 1987). However, the resulting diastereomeric mixture can only be resolved in the case of relatively short sequences.…”
Section: Resultsmentioning
confidence: 99%
“…Synthesis of Oligodeoxyribonucleoside Methylphosphonates. The methylphosphonate oligomers were synthesized on a 1% cross-linked polystyrene support using 5'-(dimethoxytrityl)nucleoside 3'-(methylphosphonic imidazolide) intermediates (Miller et al, 1986) or on a controlled-pore glass support using 5/-(dimethoxytrityl)nucleoside 3,-[[(iV,7V-diisopropylamino)methyl]phosphonamidite] intermediates (Dorman et al, 1984;Jager & Engels, 1984;Marcus-Sekura et al, 1987) which were purchased from American Bionetics Inc. To suppress formation of 4-(2-aminoethyl)cytosine during the deblocking procedure (Miller et al, 1986), the support was treated overnight with a solution containing 1.2 mL of pyridine, 0.3 mL of glacial acetic acid, and 0.05 mL of 85% hydrazine hydrate to remove benzoyl groups from cytosine and adenine residues of the protected oligomer (Letsinger et al, 1968). The partially deprotected oligomer was then further deprotected and cleaved from its support by sequential treatment with 50% ethylenediamine in ethanol and with 80% acetic acid.…”
mentioning
confidence: 99%
“…with the 5'-hydroxyl group of an oligonucleotide followed by oxidation (the last method is suitable for a solid phase synthesis) result in a mixture of P-diastereoisomers [37][38][39][40]. Although the latter monomers can be separated into P-diastereomers, they are known to undergo a rapid epimerisation in the presence of tetrazole [41].…”
Section: Methylphosphonatesmentioning
confidence: 99%